Dopamine Agonists in the Management of Non-Functioning Pituitary Adenomas. [PDF]
Acta Endocrinol (Buchar), 2021 Capatina C, Poiana C.
europepmc +1 more source
Behavioral studies of the effects of dopamine and 5-HT1A agonists in cynomolgus monkeys
, 1989 Eiji Mizuta +2 more
openalex +1 more source
Molecular Tools to Study and Control Dopaminergic Neurotransmission With Light
Medicinal Research Reviews, EarlyView.ABSTRACT Dopaminergic neurotransmission is involved in several important brain functions, such as motor control, learning, reward‐motivated behavior, and emotions. Dysfunctions of dopaminergic system may lead to the development of various neurological and psychiatric disorders, like Parkinson's disease, schizophrenia, depression, and addictions ...
Galyna Maleeva +5 more
wiley +1 more source
Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein. [PDF]
Bioorg Med Chem, 2023 Dinda B +8 more
europepmc +1 more source
Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach
, 1990 Romain A. Lefebvre +2 more
openalex +2 more sources
Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis. [PDF]
Chin Neurosurg J, 2022 Cai X +5 more
europepmc +1 more source
GABA in the Deep Layers of the Superior Colliculus/Mesencephalic Reticular Formation Mediates the Enhancement of Startle by the Dopamine D1Receptor Agonist SKF 82958 in Rats [PDF]
, 2000 Edward G. Meloni, Michael J. Davis
openalex +1 more source
Recent Advances in Mammalian Olfactory Receptor Function and Structure
Sensory Neuroscience, EarlyView.Olfactory receptors (ORs), a subset of G protein‐coupled receptors (GPCRs), mediate odor detection in sensory neurons and regulate diverse physiological functions across tissues. Their roles in metabolism, immunity, and neural processes underscore their therapeutic relevance. Recent high‐resolution Cryo‐EM studies have unveiled OR activation mechanisms,
Hongxi Qin +9 more
wiley +1 more source
Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists. [PDF]
Front Endocrinol (Lausanne), 2021 Tang H +5 more
europepmc +1 more source
Dopamine agonists: their role in the treatment of Parkinson's disease [PDF]
, 2000 David J. Brooks
openalex +1 more source